About
Cancer Diagnostics, Inc. (CDI) manufactures, develops and supplies products for the worldwide anatomical pathology market. (Surgical Pathology, Histology, Cytology, & Immunohistochemistry). Founded in 1998, CDI developed the first commercially available 7-dye color kit for marking and identifying cancer margins and today has grown into one of the industry's largest providers to anatomical pathology serving over 6,000 customers throughout the world.
Technologies
NetSuiteOracle CloudMobile FriendlyRemote
Keywords
anatomical pathologyhistologyimmunohistochemistrysurgical pathologycytologymedical equipment manufacturingvolume controlled paraffin dispensersmedical equipment and supplies manufacturingfixativesparaffin dispensershistocool blocksstainersembedding centersslide printershealthcare equipment and supplies manufacturingmicroarraystissue processingb2bscientific research and development servicesfda cgmpkatana blade technologycryostattissue marking dyese-commerceiso 13485medical laboratoriesvolume optimized kitsmicrotomeshistology dyespureaffin histology waxes
Company Information
- Employees35
- Founded1998
- Annual Revenue$23585000
Location
116 Page Point Cir, Durham, North Carolina, United States, 27703-9120
